OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2 and holds potential for research on kidney fibrosis and chronic kidney disease [1].
Molecular Weight:
907.03
Formula:
C42H62N14O9
Target:
EGFR|||STAT
* VAT and and shipping costs not included. Errors and price changes excepted
